Formulation of Risperidone as Self-Nanoemulsifying Drug Delivery System in Form of Effervescent Tablets

Journal of Dispersion Science and Technology

Volumn 33, Issue 8, 2012, Pages 1127-1133

  Soliman, Kareem AbuBakr ^a   Ibrahim, Howida Kamal ^a   Ghorab, Mahmoud Mohamed ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Aeroperl; effervescent tablets; nanoemulsion; risperidone

Indexed keywords

AEROPERL; ANTIPSYCHOTIC DRUG; DRUG DELIVERY SYSTEM; DRUG DISSOLUTION; DRUG RELEASE; EFFERVESCENT TABLETS; FACTORIAL DESIGN; NANOEMULSION; PATIENT COMPLIANCE; RISPERIDONE; TABLET FORMULATIONS; WATER SOLUBILITIES;

DRUG PRODUCTS;

DRUG DELIVERY;

EID: 84864569544     PISSN: 01932691     EISSN: 15322351     Source Type: Journal    
DOI: 10.1080/01932691.2011.599235     Document Type: Article

References (28)

1. Houthoofd, S.A., Morrens, M., and Sabbe, B.G. (2008) Clin. Ther., 30: 1565-1589.
2. U.S. Food and Drug Aadministration (2006) FDA approves the first drug to treat irritability associated with autism, Risperdal. [Press Release]. Available from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2006/ucm108759.htm
3. Ereshefsky, L. and Lacombe, S. (1993) Can. J. Psychiatry, 38 (Suppl. 3): S80-S88.
4. Huang, M.L., et al. (1993) Clin. Pharmacol. Ther., 54: 257-268.
5. Kumar, M., Pathak, K., and Misra, A. (2009) Drug Dev. Ind. Pharm., 35: 387-395.
6. Lawrence, M.J. and Rees, G.D. (2000) Adv. Drug Deliv. Rev., 45: 89-121.
7. Constantinides, P.P. (1995) Pharm. Res., 12: 1561-1572.
8. Pouton, C.W. (1997) Adv. Drug Deliv. Rev., 25: 47-58.
9. Pouton, C.W. (2000) Eur. J. Pharm. Sci., 11 (Suppl 2): S93-S98.
10. Gursoy, R.N. and Benita, S. (2004) Biomed. Pharmacother., 58: 173-82.
11. Pouton, C.W. (1985) Int. J. Pharm., 27: 335-348.
12. Charman, S.A., et al. (1992) Pharm. Res., 9: 87-93.
13. Shah NH, C.M., Patel, C.I., Infeld, M.H., Malick, A.W. (1994) Int. J. Pharm., 106: 15-23.
14. El Maghraby, G.M. (2008) Int. J. Pharm., 355: 285-292.
15. Panda, A.K., Moulik, S.P., Bhowmik, B.B., and Das, A.R. (2001) J. Colloid Interface Sci., 235: 218-226.
16. Zhang, X.G., Dong, F.J., Zhang, Y.G., Zhou, X.H., and Hong, X.L. (2006) Acta Physico-Chimica Sinica, 22: 22-27.
17. Porter, C.J., et al. (2004) Pharm. Res., 21: 1405-1412.
18. Goddeeris, C., et al. (2006) Int. J. Pharm., 312: 187-195.
19. Zhang, L., Zhang, D.B., Ma, M.J., Cheng, H.M., and Qi, L.M. (2003) Acta Physico-Chimica Sinica, 19: 120-125.
20. Badawi, A.A., et al. (2008) Arch. Pharm. Res., 31: 1040-1049.
21. Zanowiak, P. (1990) In Encyclopedia of Pharmaceutical Technology, edited by J.C.B. James Swarbrick. Vol. 9. New York: Marcel Dekker, 87-112.
22. Peck, G.E., Bailey, G.J., McCurdy, V.E., and Banker, G.S. (1989) In Pharmaceutical Dosage Forms: Tablets (), 2nd ed., edited by L.L. Herbert, A. Lieberman, and Joseph B. Scwartz. Vol. 1. New York: Marcel Dekker, 85-87.
23. Kawakami, K., et al. (2002) J. Control. Rel., 81: 65-74.
24. Ghosh, P.K., et al. (2006) AAPS Pharm Sci Tech., 7: E172-177.
25. Xiong, J., et al. (2008) Drug Dev. Ind. Pharm., 34: 65-72.
26. Bouchemal, K., et al. (2004) Int. J. Pharm., 280: 241-251.
27. Pal, R. (1998) Colloids Surf. A, 137: 275-286.
28. Morey, T.E., et al. (2006) Anesthesiology, 10: 1184-1190.